Cap problem leads to recall

Anticonvulsant recalled due to issue with child-resistant caps Pfizer Australia, in consultation with the TGA, has initiated a recall for product correction for bottles of phenytoin 30 mg capsules, 100 mg capsules and 50 mg tablets, which are marketed under the brand name Dilantin. According to advice provided by the TGA bottles of Dilantin may